Twin Gains For Novartis In India Ribociclib, Ceritinib Patent Cases

 
• By Anju Ghangurde

Novartis gains upper hand for now, staving off challenge to patents on its oncology drugs ribociclib and ceritinib in India by seasoned opponent Natco, though things appear far from over in the case.

Gavel scales law book (Proxima Studio/Shutterstock.com)
Court Rulings Give Novartis Upper Hand In Indian Patent Case • Source: Shutterstock

More from Business

More from Scrip